Kala Pharmaceuticals Inc. buy Oppenheimer Holdings Inc.
Start price
01.04.24
/
50%
€7.29
Target price
01.04.25
€13.96
Performance (%)
-32.11%
End price
02.04.25
€4.95
Summary
This prediction ended on 02.04.25 with a price of €4.95. Massive losses of -32.11% were the result for the BUY prediction by Oppenheimer_Holdings. Oppenheimer_Holdings has a follow-up prediction for Kala Pharmaceuticals Inc. where he still thinks Kala Pharmaceuticals Inc. is a Buy. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Kala Pharmaceuticals Inc. | -20.171% | -20.171% | -89.200% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Kala Pharmaceuticals diskutieren
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Ratings data for KALA provided by MarketBeat
In the thread Trading Kala Pharmaceuticals Inc.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Current prediction by Oppenheimer_Holdings for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.07
02.06.25
02.06.25
€13.19
02.06.26
02.06.26
-83.20%
15.12.25
15.12.25
Stopped prediction by Oppenheimer_Holdings for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.52
11.09.25
11.09.25
€28.21
11.09.26
11.09.26
-96.18%
15.12.25
15.12.25
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.39
19.08.24
19.08.24
€13.55
19.08.25
19.08.25
28.32%
20.08.25
20.08.25